Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Buccaline
Active Ingredients: Haemophilus influenzae type b 1500million organisms
Pneumococcus I,II,III 1000million organisms
Staphylococcus aureus 1000million organisms
Streptococcus agalactiae 1000million organisms
Dosage Form: Tablet
New Zealand Sponsor: Pharmabroker Sales Limited
Manufacturer: Laboratorio Farmaceutico SIT S.r.l, Pavia, Italy
Dated this 14th day of February 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).